- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Picker bolsters PACS operations
Picker bolsters PACS operationsPicker International has been active in building its Image Management division, adding new staff and reconfiguring its business. Beccie Mendenhall has been promoted to manager of a newly created solutions group,
Picker bolsters PACS operations
Picker International has been active in building its Image Management division, adding new staff and reconfiguring its business. Beccie Mendenhall has been promoted to manager of a newly created solutions group, which has been formed to manage customer projects and provide professional services to customers. Picker has also hired Robert Crawford to lead the firms integration services group, which will support Picker/third party integration assoc- iated with DICOM, for both Pickers PACS and modality businesses. Crawford comes to Picker from Agfa, where he led a similar group.
In other moves, Steve House has been promoted to global sales manager. House has been with Picker for the past 18 months, and previously served as a regional sales manager for Cemax-Icon.
Tom Pacenta continues as marketing manager, while Dr. Tim Cramer has taken on responsibility for Pickers solutions, integration services, and marketing organizations. Cramer also retains his previous role as medical director for the Image Management group and director of corporate connectivity for Picker.
The Cleveland, OH-based firm has also hired two new sales specialists. Jonathan Sharf joins Picker from Merge Technologies, and has also served as a sales representative at Imation. Greg Olivieri, who joins the company from Swissray, was formerly the educational director of the Staten Island University Hospital School of Radiological Sciences.
- Search again
- Homepage
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
